object
infect
diagnosi
challeng
patient
week
onset
symptom
due
low
posit
rate
pcr
serolog
test
could
complementari
pcr
situat
aim
studi
analyz
diagnost
perform
one
serolog
rapid
test
patient
method
evalu
immunochromatograph
test
alltest
igg
igm
detect
igg
igm
antibodi
valid
serolog
test
use
serum
sampl
neg
patient
group
patient
confirm
pcr
group
prospect
evalu
test
patient
clinic
diagnosi
pneumonia
unknown
etiolog
neg
pcr
group
pandem
due
start
wuhan
four
month
ago
caus
april
total
case
death
worldwid
spain
countri
european
region
affect
infect
account
case
death
april
begin
pandem
one
main
concern
complex
limit
led
develop
differ
micropl
elisa
test
recent
publish
studi
confirm
use
combin
pcr
nasopharyng
exud
detect
igm
igg
antibodi
blood
combin
molecular
serolog
techniqu
allow
author
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
popul
studi
period
includ
three
group
patient
studi
prospect
studi
valid
serolog
test
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
group
patient
posit
pcr
use
evalu
sensit
serolog
test
use
pcr
gold
standard
total
confirm
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
tabl
within
first
week
igm
igg
p
respect
tabl
reach
sensit
day
onset
symptom
figur
show
evolut
posit
rate
test
group
igm
antibodi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
studi
show
alltest
igg
igm
rapid
test
detect
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
best
knowledg
studi
first
evalu
serolog
rapid
test
complet
data
time
onset
symptom
serolog
test
kind
inform
key
order
interpret
properli
sensit
specif
result
addit
experi
use
test
studi
subject
limit
first
conduct
singl
hospit
multicent
studi
necessari
reinforc
find
second
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
question
reliabl
serolog
rapid
test
still
debat
research
need
topic
think
studi
may
help
point
use
rapid
test
author
declar
conflict
interest
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
